OPAXIO Trademark

Trademark Overview

On Wednesday, August 26, 2009, a trademark application was filed for OPAXIO with the United States Patent and Trademark Office. The USPTO has given the OPAXIO trademark a serial number of 77813026. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 13, 2013. This trademark is owned by Novartis AG. The OPAXIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders
opaxio

General Information

Serial Number77813026
Word MarkOPAXIO
Filing DateWednesday, August 26, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 13, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 19, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 2, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, May 13, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 13, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 16, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 15, 2012EXTENSION 5 GRANTED
Friday, October 12, 2012EXTENSION 5 FILED
Friday, October 12, 2012TEAS EXTENSION RECEIVED
Saturday, April 7, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 6, 2012EXTENSION 4 GRANTED
Wednesday, April 4, 2012EXTENSION 4 FILED
Wednesday, April 4, 2012TEAS EXTENSION RECEIVED
Thursday, September 22, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 21, 2011EXTENSION 3 GRANTED
Monday, September 19, 2011EXTENSION 3 FILED
Monday, September 19, 2011TEAS EXTENSION RECEIVED
Friday, April 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 14, 2011EXTENSION 2 GRANTED
Monday, April 11, 2011EXTENSION 2 FILED
Thursday, April 14, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 11, 2011TEAS EXTENSION RECEIVED
Wednesday, October 13, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 11, 2010EXTENSION 1 GRANTED
Monday, October 11, 2010EXTENSION 1 FILED
Monday, October 11, 2010TEAS EXTENSION RECEIVED
Tuesday, April 13, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 19, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 19, 2010PUBLISHED FOR OPPOSITION
Tuesday, December 15, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 15, 2009ASSIGNED TO LIE
Tuesday, December 1, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 1, 2009ASSIGNED TO EXAMINER
Wednesday, September 2, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 1, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

opaxio diseases disorders oncological treatment preparations substances pharmaceutical